Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCizzle Biotech Regulatory News (CIZ)

Share Price Information for Cizzle Biotech (CIZ)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.70
Bid: 1.60
Ask: 1.80
Change: 0.00 (0.00%)
Spread: 0.20 (12.50%)
Open: 1.70
High: 1.70
Low: 1.70
Prev. Close: 1.70
CIZ Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

7 Dec 2021 17:31

RNS Number : 8905U
Cizzle Biotechnology Holdings PLC
07 December 2021
 

 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

Cizzle Biotechnology Holdings PLC

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

X

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

change in percentage of voting rights arising upon a new issue of shares by the issuer

3. Full name of person(s) subject to thenotification obligation: iii

Enterprise Ventures Limited

4. Full name of shareholder(s) (if different from 3.):iv

Finance Yorkshire Seedcorn Fund LP

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

25th November 2021

6. Date on which issuer notified:

7th December 2021

7. Threshold(s) that is/are crossed orreached: vi, vii

9%

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights

Direct

Direct xi

Indirecti

Direct

Indirect

CIZ

24,437,410

24,437,410

23,437,410

23,437,410

Nil

8.99

Nil

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

None

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

None

 

 

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

23,437,410

8.99%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

 

 

Proxy Voting:

10. Name of the proxy holder:

11. Number of voting rights proxy holder will ceaseto hold:

12. Date on which proxy holder will cease to holdvoting rights:

13. Additional information:

14. Contact name:

Enterprise Ventures Limited

15. Contact telephone number:

 01772 270 570

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLUBUBRAWUURAA
Date   Source Headline
24th Jun 202412:42 pmRNSResult of AGM
17th Jun 20247:00 amRNSUpdate on North American Strategic Licensing MoU
3rd Jun 20247:00 amRNSNotice of Annual General Meeting
13th May 20247:00 amRNSHolding(s) in Company
30th Apr 20245:00 pmRNSTotal Voting Rights
30th Apr 20249:12 amRNSFinal results for the year ended 31 December 2023
23rd Apr 202411:20 amRNSHolding(s) in Company
2nd Apr 20247:00 amRNSLicensing and Partnership MoU for North America
26th Mar 20247:00 amRNSPlacing to raise £0.62 million
28th Sep 20237:00 amRNSInterim Results
21st Sep 20237:00 amRNSUpdate on Put Option with Conduit
19th Sep 20237:00 amRNSCompletion of Evaluation Programme with Bio-Techne
8th Sep 20237:03 amRNSExtension of and update on Put Option with Conduit
15th Aug 20237:00 amRNSUpdate on Put Option with Conduit
10th Aug 20237:00 amRNSExpansion of Research Agreement and CIZ1B Update
30th Jun 20235:00 pmRNSTotal Voting Rights
28th Jun 202312:01 pmRNSResult of AGM
12th Jun 20232:15 pmRNSTotal Voting Rights
12th Jun 20237:00 amRNSSubscription to raise £350,000
5th Jun 202312:35 pmRNSPosting of Annual Report and Notice of AGM
15th May 20231:42 pmRNSUpdate on Royalty Sharing Agreement in AZD1656
27th Apr 20237:00 amRNSResults for the year ended 31 December 2022
24th Apr 20237:00 amRNSNew Research Agreement with the University of York
30th Mar 202311:05 amRNSSecond Price Monitoring Extn
30th Mar 202311:00 amRNSPrice Monitoring Extension
17th Mar 20234:35 pmRNSPrice Monitoring Extension
13th Mar 20239:00 amRNSPrice Monitoring Extension
7th Mar 20237:00 amRNSIssue of Options in lieu of salary increases
22nd Feb 20237:52 amRNSHolding(s) in Company
6th Feb 20237:02 amRNSHolding(s) in Company
31st Jan 20235:00 pmRNSTotal Voting Rights
24th Jan 202312:48 pmRNSHolding(s) in Company
20th Dec 20223:17 pmRNSUpdate re. timing of Admission
19th Dec 20227:00 amRNSPut Option re AZD1656 & £115,586 Subscription
23rd Nov 20228:04 amRNSClinical Study for Lung Cancer Detection in China
9th Nov 20227:00 amRNSConduit Pharmaceuticals Proposed Listing
31st Oct 20225:00 pmRNSTotal Voting Rights
4th Oct 20228:00 amRNSAdmission and Total Voting Rights
30th Sep 20225:00 pmRNSTotal Voting Rights
29th Sep 20223:49 pmRNSIssue of Consideration Shares & Option Exercise
28th Sep 20223:05 pmRNSHolding(s) in Company
28th Sep 20227:00 amRNSInterim results
26th Sep 20228:00 amRNSAdmission and Total Voting Rights
21st Sep 202211:23 amRNSSubscription, Facility & Publication of Prospectus
18th Aug 20229:21 amRNSArcadia Clinical Trial Results Published
10th Aug 20224:41 pmRNSSecond Price Monitoring Extn
10th Aug 20224:36 pmRNSPrice Monitoring Extension
11th Jul 20227:15 amEQSHardman & Co Research: Cizzle Biotechnology (CIZ): Considerable progress in first year since listing
5th Jul 20227:00 amRNSUpdate on Development of Proprietary Antibodies
27th Jun 202211:52 amRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.